HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells (Q54559603)

31 May 2018

title

HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells (English)

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

12 December 2024

1 reference

17

Lin-Tao Jia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21925125

12 December 2024

18

Lin-Tao Jia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21925125

12 December 2024

author name string

Wei Bao

1

1 reference

31 May 2018

Hai-Jing Fu

2

1 reference

31 May 2018

Qiao-Sheng Xie

3

1 reference

31 May 2018

Lei Wang

4

1 reference

31 May 2018

Rui Zhang

5

1 reference

31 May 2018

Zhang-Yan Guo

6

1 reference

31 May 2018

Jing Zhao

7

1 reference

31 May 2018

Yan-Ling Meng

8

1 reference

31 May 2018

Xin-Ling Ren

9

1 reference

31 May 2018

Tao Wang

10

1 reference

31 May 2018

Qing Li

11

1 reference

31 May 2018

Bo-Quan Jin

12

1 reference

31 May 2018

Li-Bo Yao

13

1 reference

31 May 2018

Rui-An Wang

14

1 reference

31 May 2018

Dai-Ming Fan

15

1 reference

31 May 2018

Si-Yi Chen

16

1 reference

31 May 2018

An-Gang Yang

18

1 reference

31 May 2018

language of work or name

English

0 references

publication date

16 September 2011

1 reference

31 May 2018

full work available at URL

http://www.gastrojournal.org/article/S0016508511012479/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21925125

https://api.elsevier.com/content/article/PII:S0016508511012479?httpAccept=text/xml

12 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

https://api.elsevier.com/content/article/PII:S0016508511012479?httpAccept=text/plain

12 December 2024

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

12 December 2024

1 reference

31 May 2018

volume

141

1 reference

31 May 2018

issue

6

1 reference

31 May 2018

page(s)

2076-2087.e6

1 reference

31 May 2018

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

cites work

1

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

A molecular signature of metastasis in primary solid tumors

12 December 2024

2

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

12 December 2024

3

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

c-erbB-2 expression in primary gastric carcinomas and their metastases

12 December 2024

4

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Tyrosine kinases and gastric cancer

12 December 2024

5

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Humanization of an anti-p185HER2 antibody for human cancer therapy

12 December 2024

6

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

12 December 2024

7

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer

12 December 2024

8

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Involvement of chemokine receptors in breast cancer metastasis

12 December 2024

9

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone

12 December 2024

10

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

12 December 2024

11

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

12 December 2024

12

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

12 December 2024

13

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

12 December 2024

14

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

MicroRNA control of signal transduction

12 December 2024

15

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

The microRNA network and tumor metastasis

12 December 2024

16

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion

12 December 2024

17

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Design of LNA probes that improve mismatch discrimination

12 December 2024

18

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects

12 December 2024

19

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter

12 December 2024

20

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth

12 December 2024

21

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread

12 December 2024

22

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Mi-2/NuRD: multiple complexes for many purposes

12 December 2024

23

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor

12 December 2024

24

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

12 December 2024

25

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

CD44: from adhesion molecules to signalling regulators

12 December 2024

27

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

12 December 2024

28

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

RAS is regulated by the let-7 microRNA family

12 December 2024

29

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

MicroRNAs and cancer epigenetics: a macrorevolution

12 December 2024

30

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Overexpression of theMTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis

12 December 2024

31

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Trastuzumab--mechanism of action and use in clinical practice

12 December 2024

32

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

12 December 2024

33

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Histone deacetylase inhibitors in cancer therapy

12 December 2024

34

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Anti-inflammatory Agents: Present and Future

12 December 2024

35

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels

12 December 2024

36

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells

12 December 2024

37

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery.

12 December 2024

38

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion

12 December 2024

39

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

12 December 2024

40

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma

12 December 2024

41

1 reference

https://api.crossref.org/works/10.1053/J.GASTRO.2011.08.050

12 December 2024

Identifiers

1 reference

31 May 2018

1 reference

31 May 2018